435 related articles for article (PubMed ID: 33673861)
21. 18F-FDG PET/CT and HRCT: a combined tool for risk stratification in idiopathic inflammatory myopathy-associated interstitial lung disease.
Zhang Y; Chen Z; Long Y; Zhang B; He Q; Tang K; Zhang X
Clin Rheumatol; 2022 Oct; 41(10):3095-3105. PubMed ID: 35759126
[TBL] [Abstract][Full Text] [Related]
22. FDG-PET/CT in the prediction of pulmonary function improvement in nonspecific interstitial pneumonia. A Pilot Study.
Jacquelin V; Mekinian A; Brillet PY; Nunes H; Fain O; Valeyre D; Soussan M
Eur J Radiol; 2016 Dec; 85(12):2200-2205. PubMed ID: 27842667
[TBL] [Abstract][Full Text] [Related]
23. Quantitative computed tomography assessment for systemic sclerosis-related interstitial lung disease: comparison of different methods.
Ufuk F; Demirci M; Altinisik G
Eur Radiol; 2020 Aug; 30(8):4369-4380. PubMed ID: 32193641
[TBL] [Abstract][Full Text] [Related]
24. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI
Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
[TBL] [Abstract][Full Text] [Related]
25. Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease.
Takei R; Arita M; Kumagai S; Ito Y; Tokioka F; Koyama T; Saito R; Nishimura K; Tokumasu H; Ishida T
Respirology; 2018 Apr; 23(4):385-391. PubMed ID: 28925574
[TBL] [Abstract][Full Text] [Related]
26. Predictors of progression in systemic sclerosis patients with interstitial lung disease.
Distler O; Assassi S; Cottin V; Cutolo M; Danoff SK; Denton CP; Distler JHW; Hoffmann-Vold AM; Johnson SR; Müller Ladner U; Smith V; Volkmann ER; Maher TM
Eur Respir J; 2020 May; 55(5):. PubMed ID: 32079645
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal change during follow-up of systemic sclerosis: correlation between high-resolution computed tomography and pulmonary function tests.
Carnevale A; Silva M; Maietti E; Milanese G; Saracco M; Parisi S; Bravi E; De Gennaro F; Arrigoni E; Bodini FC; Fusaro E; Scirè CA; Sverzellati N; Ariani A
Clin Rheumatol; 2021 Jan; 40(1):213-219. PubMed ID: 32880053
[TBL] [Abstract][Full Text] [Related]
28. Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.
Antoniou KM; Margaritopoulos GA; Goh NS; Karagiannis K; Desai SR; Nicholson AG; Siafakas NM; Coghlan JG; Denton CP; Hansell DM; Wells AU
Arthritis Rheumatol; 2016 Apr; 68(4):1004-12. PubMed ID: 26636545
[TBL] [Abstract][Full Text] [Related]
29. Novel Imaging Approaches in Systemic Sclerosis-Associated Interstitial Lung Disease.
Montesi SB; Caravan P
Curr Rheumatol Rep; 2019 Apr; 21(6):25. PubMed ID: 31025121
[TBL] [Abstract][Full Text] [Related]
30. Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels.
Occhipinti M; Bosello S; Sisti LG; Cicchetti G; de Waure C; Pirronti T; Ferraccioli G; Gremese E; Larici AR
PLoS One; 2019; 14(3):e0213444. PubMed ID: 30861018
[TBL] [Abstract][Full Text] [Related]
31. Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis.
Barskova T; Gargani L; Guiducci S; Randone SB; Bruni C; Carnesecchi G; Conforti ML; Porta F; Pignone A; Caramella D; Picano E; Cerinic MM
Ann Rheum Dis; 2013 Mar; 72(3):390-5. PubMed ID: 22589373
[TBL] [Abstract][Full Text] [Related]
32. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
[TBL] [Abstract][Full Text] [Related]
33. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y
Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031
[TBL] [Abstract][Full Text] [Related]
34. Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT.
Occhipinti M; Bruni C; Camiciottoli G; Bartolucci M; Bellando-Randone S; Bassetto A; Cuomo G; Giuggioli D; Ciardi G; Fabbrizzi A; Tomassetti S; Lavorini F; Pistolesi M; Colagrande S; Matucci-Cerinic M
Ann Rheum Dis; 2020 Sep; 79(9):1210-1217. PubMed ID: 32606043
[TBL] [Abstract][Full Text] [Related]
35. Computer-Aided Tomographic Analysis of Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc). Correlation with Pulmonary Physiologic Tests and Patient-Centred Measures of Perceived Dyspnea and Functional Disability.
Salaffi F; Carotti M; Di Donato E; Di Carlo M; Ceccarelli L; Giuseppetti G
PLoS One; 2016; 11(3):e0149240. PubMed ID: 26930658
[TBL] [Abstract][Full Text] [Related]
36. Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation.
Broens B; van der Laken CJ; Zwezerijnen GJC; Nossent EJ; Meijboom LJ; Spierings J; de Vries-Bouwstra JK; van Laar JM; Voskuyl AE
Front Immunol; 2022; 13():923869. PubMed ID: 35865521
[TBL] [Abstract][Full Text] [Related]
37. Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort.
Hoffmann-Vold AM; Fretheim H; Halse AK; Seip M; Bitter H; Wallenius M; Garen T; Salberg A; Brunborg C; Midtvedt Ø; Lund MB; Aaløkken TM; Molberg Ø
Am J Respir Crit Care Med; 2019 Nov; 200(10):1258-1266. PubMed ID: 31310156
[No Abstract] [Full Text] [Related]
38. Pulmonary Artery Dimensions as a Prognosticator of Transplant-Free Survival in Scleroderma Interstitial Lung Disease.
Gleason JB; Patel KB; Hernandez F; Hadeh A; Highland KB; Rahaghi F; Mehta JP
Lung; 2017 Aug; 195(4):403-409. PubMed ID: 28456874
[TBL] [Abstract][Full Text] [Related]
39. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.
Khanna D; Tashkin DP; Denton CP; Renzoni EA; Desai SR; Varga J
Am J Respir Crit Care Med; 2020 Mar; 201(6):650-660. PubMed ID: 31841044
[TBL] [Abstract][Full Text] [Related]
40. The Value of Ultrasound for Detecting and Following Subclinical Interstitial Lung Disease in Systemic Sclerosis.
Gutierrez M; Bertolazzi C; Zozoaga-Velazquez E; Clavijo-Cornejo D
Tomography; 2024 Apr; 10(4):521-532. PubMed ID: 38668398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
